The Net Margin of Jenburkt Pharmaceuticals Ltd (524731.BO) is 18.30%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | 18.30% |
| 2023-03-31 | 17.99% |
| 2022-03-31 | 17.98% |
| 2021-03-31 | 15.10% |
| 2020-03-31 | 12.51% |
| 2019-03-31 | 16.14% |
| 2018-03-31 | 15.01% |
| 2017-03-31 | 13.08% |
| 2016-03-31 | 11.52% |
| 2015-03-31 | 11.32% |